These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7160937)

  • 1. Effects of prostaglandin E2 on the survival time of fulminant hepatic failure rats.
    Dixit V; Chang TM
    Int J Artif Organs; 1982 Nov; 5(6):388. PubMed ID: 7160937
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary report on effects of prostaglandin E2 on brain edema in fulminant hepatic failure rats.
    Dixit V; Chang TM
    Int J Artif Organs; 1985 Jan; 8(1):55-6. PubMed ID: 3855843
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of polylactic acid microcapsules containing prostaglandin E2 on the survival rates of grade II coma galactosamine induced fulminant hepatic failure rats.
    Zhou MX; Chang TM
    Biomater Artif Cells Artif Organs; 1987; 15(3):549-58. PubMed ID: 3481554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prostaglandin E2 on brain edema and liver histopathology in a galactosamine-induced fulminant hepatic failure rat model.
    Dixit V; Chang TM
    Biomater Artif Cells Artif Organs; 1987; 15(3):559-73. PubMed ID: 3481555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective cyclooxygenase inhibition improves hepatic encephalopathy in fulminant hepatic failure of rat.
    Chang CC; Wang SS; Huang HC; Chan CY; Lee FY; Lin HC; Nong JY; Chuang CL; Lee SD
    Eur J Pharmacol; 2011 Sep; 666(1-3):226-32. PubMed ID: 21575628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on variation of plasma gamma-aminobutyric acid concentration in rat model of hepatic encephalopathy due to fulminant hepatic failure].
    He X; Luan Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):45-8. PubMed ID: 1398623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of hepatic encephalopathy in rats with thioacetamide-induced acute liver failure by serotonin antagonists.
    Yurdaydin C; Herneth AM; Püspök A; Steindl P; Singer E; Ferenci P
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):667-71. PubMed ID: 8853256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of prostaglandin E2 on experimental mesenteric ischemia in rats].
    Fernández Alonso A; Martínez Rodríguez E; Vega Alvarez JA
    Rev Esp Enferm Apar Dig; 1987 Dec; 72(6):659-65. PubMed ID: 3481448
    [No Abstract]   [Full Text] [Related]  

  • 9. Action of somatostatin analogue (octreotide) on experimental hepatic encephalopathy in rats.
    Kapicioglu S; Savaskan H; Ozdemir F; Baki AH; Kaynar K
    Hepatogastroenterology; 2000; 47(34):1060-2. PubMed ID: 11020879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic nephritis prevention by prostaglandins E2 and F2 alpha.
    Păuşescu E; Laki D; Popescu MV; Chiper-Stancu D
    Clin Nephrol; 1984 Mar; 21(3):169-73. PubMed ID: 6584257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of six artificial liver support regimes in fulminant hepatic coma rats.
    Tabata Y; Chang TM
    Trans Am Soc Artif Intern Organs; 1980; 26():394-9. PubMed ID: 7245521
    [No Abstract]   [Full Text] [Related]  

  • 12. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of nitric oxide synthase isoforms.
    Chu CJ; Chang CC; Wang TF; Lee FY; Chang FY; Chen YC; Chan CC; Huang HC; Wang SS; Lee SD
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1194-9. PubMed ID: 16824075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid antagonists.
    Yurdaydin C; Li Y; Ha JH; Jones EA; Rothman R; Basile AS
    J Pharmacol Exp Ther; 1995 Apr; 273(1):185-92. PubMed ID: 7714765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal fulminant hepatic failure due to sodium valproate in an adolescent.
    Puri AS; Sharma BC; Khan EM; Saraswat VA
    Indian Pediatr; 1994 Feb; 31(2):207-10. PubMed ID: 7875849
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental studies on some effects of prostaglandin E2 in acute renal failure.
    Mitra K; De MK
    J Indian Med Assoc; 1990 Jan; 88(1):10-3. PubMed ID: 2362130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light microscopic quantitative investigation on the effects of prostaglandin E2 (PGE2) on the lectin binding pattern in rat gastric mucosa injured by ethanol or sodium taurocholate.
    Fringes B; Klein PJ; Lorenz D; Oehlert W
    Acta Histochem Suppl; 1988; 36():263-72. PubMed ID: 3150559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Decreased dopaminergic activity in hepatic encephalopathy in rats with galactosamine-induced acute liver failure].
    Yamada A; Takeuchi H; Miki H; Touge T; Nishioka M
    No To Shinkei; 1992 Feb; 44(2):103-9. PubMed ID: 1567728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of prostaglandin E2 on pancreatic islet B cells of rats with alloxan induced diabetes.
    Wang JL; Zhu WY; Wang ZJ
    Chin Med J (Engl); 1988 Mar; 101(3):165-70. PubMed ID: 3136990
    [No Abstract]   [Full Text] [Related]  

  • 19. An animal model of fulminant hepatic failure in the rat.
    Watanabe A; Higashi T; Nagashima H
    Acta Med Okayama; 1979 Dec; 33(6):443-50. PubMed ID: 161469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioacetamide-induced hepatic encephalopathy in the rat. I. Preliminary morphological and biochemical observations.
    Hilgier W; Albrecht J; Kraśnicka Z
    Neuropatol Pol; 1983; 21(4):487-94. PubMed ID: 6669229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.